Titel

Merkliste
1 Ergebnisse

Uncovering the mode of action of engineered T cells in pati..:

Dekkers, Johanna F ; Alieva, Maria ; Cleven, Astrid...
Dekkers , J F , Alieva , M , Cleven , A , Keramati , F , Wezenaar , A K L , van Vliet , E J , Puschhof , J , Brazda , P , Johanna , I , Meringa , A D , Rebel , H G , Buchholz , M-B , Barrera Román , M , Zeeman , A L , de Blank , S , Fasci , D , Geurts , M H , Cornel , A M , Driehuis , E , Millen , R , Straetemans , T , Nicolasen , M J T , Aarts-Riemens , T , Ariese , H C R , Johnson , H R , van Ineveld , R L , Karaiskaki , F , Kopper , O , Bar-Ephraim , Y E , Kretzschmar , K , Eggermont , A M M , Nierkens , S , Wehrens , E J , Stunnenberg , H G , Clevers , H , Kuball , J , Sebestyen , Z & Rios , A C 2023 , ' Uncovering the mode of action of engineered T cells in patient cancer organoids ' , Nature Biotechnology , vol. 41 , no. 1 , pp. 60-69 . https://doi.org/10.1038/s41587-022-01397-w. , 2023

Link: https://pure.knaw.nl/portal/en/publications/13741c46-2..

RT Journal
T1 <Title>Uncovering the mode of action of engineered T cells in patient cancer organoids</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftknawnlpublic:oai:pure.knaw.nl:publications_13741c46-2c10-4b4a-a2f7-8b062414030d&Exemplar=1&LAN=DE
				
A1 Dekkers, Johanna F
A1 Alieva, Maria
A1 Cleven, Astrid
A1 Keramati, Farid
A1 Wezenaar, Amber K L
A1 van Vliet, Esmée J
A1 Puschhof, Jens
A1 Brazda, Peter
A1 Johanna, Inez
A1 Meringa, Angelo D
A1 Rebel, Heggert G
A1 Buchholz, Maj-Britt
A1 Barrera Román, Mario
A1 Zeeman, Amber L
A1 de Blank, Sam
A1 Fasci, Domenico
A1 Geurts, Maarten H
A1 Cornel, Annelisa M
A1 Driehuis, Else
A1 Millen, Rosemary
A1 Straetemans, Trudy
A1 Nicolasen, Mara J T
A1 Aarts-Riemens, Tineke
A1 Ariese, Hendrikus C R
A1 Johnson, Hannah R
A1 van Ineveld, Ravian L
A1 Karaiskaki, Froso
A1 Kopper, Oded
A1 Bar-Ephraim, Yotam E
A1 Kretzschmar, Kai
A1 Eggermont, Alexander M M
A1 Nierkens, Stefan
A1 Wehrens, Ellen J
A1 Stunnenberg, Henk G
A1 Clevers, Hans
A1 Kuball, Jürgen
A1 Sebestyen, Zsolt
A1 Rios, Anne C
YR 2023
K1 Humans
K1 T-Lymphocytes
K1 Neoplasms/genetics
K1 Immunotherapy/methods
K1 Organoids/pathology
JF Dekkers , J F , Alieva , M , Cleven , A , Keramati , F , Wezenaar , A K L , van Vliet , E J , Puschhof , J , Brazda , P , Johanna , I , Meringa , A D , Rebel , H G , Buchholz , M-B , Barrera Román , M , Zeeman , A L , de Blank , S , Fasci , D , Geurts , M H , Cornel , A M , Driehuis , E , Millen , R , Straetemans , T , Nicolasen , M J T , Aarts-Riemens , T , Ariese , H C R , Johnson , H R , van Ineveld , R L , Karaiskaki , F , Kopper , O , Bar-Ephraim , Y E , Kretzschmar , K , Eggermont , A M M , Nierkens , S , Wehrens , E J , Stunnenberg , H G , Clevers , H , Kuball , J , Sebestyen , Z & Rios , A C 2023 , ' Uncovering the mode of action of engineered T cells in patient cancer organoids ' , Nature Biotechnology , vol. 41 , no. 1 , pp. 60-69 . https://doi.org/10.1038/s41587-022-01397-w
LK http://dx.doi.org/https://pure.knaw.nl/portal/en/publications/13741c46-2c10-4b4a-a2f7-8b062414030d
DO https://pure.knaw.nl/portal/en/publications/13741c46-2c10-4b4a-a2f7-8b062414030d
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)